Alnylam Pharmaceuticals Inc (ALNY)

258.10 -6.37 (-2.41%) USD  |  NASDAQ  |  Nov 14, 16:00
256.21 -1.89 (-0.73%) After-Hours: 18:19
More

Alnylam Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted from Other Gain/Loss (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Pfizer Inc --
BridgeBio Pharma Inc --
Biomarin Pharmaceutical Inc --
Gilead Sciences Inc --
Regeneron Pharmaceuticals Inc --